Los Angeles Capital Management
INDV icon

Los Angeles Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Los Angeles Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.5M Buy
+82,169
New +$2.71M 0.01% 453
2025
Q4 		– Sell
-84,191
Closed -$2.03M – 2527
2025
Q3 		$2.03M Buy
+84,191
New +$1.76M 0.01% 502

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Los Angeles Capital Management's INDV Position: Q1 2026 in Review

Los Angeles Capital Management opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 82,169 shares worth $2.5M. The stake represents 0.01% of the portfolio and ranks #453 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in INDV as recently as Q3 2025.

Los Angeles Capital Management first reported a position in INDV in Q3 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Los Angeles Capital Management held 82,169 shares of Indivior Pharmaceuticals worth $2.5M as of Q1 2026.
  • Indivior Pharmaceuticals was a new Los Angeles Capital Management position in Q1 2026.
  • Indivior Pharmaceuticals made up 0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #453 holding.
  • Los Angeles Capital Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.